Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-011153
Filing Date
2023-06-15
Accepted
2023-06-15 17:26:35
Documents
14
Period of Report
2023-06-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A capr-20230612x8ka.htm   iXBRL 8-K/A 40253
2 EX-3.1 capr-20230612xex3d1.htm EX-3.1 11159
  Complete submission text file 0001558370-23-011153.txt   260784

Data Files

Seq Description Document Type Size
3 EX-101.SCH capr-20230612.xsd EX-101.SCH 3238
4 EX-101.LAB capr-20230612_lab.xml EX-101.LAB 632
5 EX-101.PRE capr-20230612_pre.xml EX-101.PRE 10461
8 EXTRACTED XBRL INSTANCE DOCUMENT capr-20230612x8ka_htm.xml XML 4872
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34058 | Film No.: 231018562
SIC: 2834 Pharmaceutical Preparations